iHEAR Medical announced the launch of the next-generation iHEARhd, a “home-programmable, invisible hearing aid for mild-to-moderate hearing losses.” The new iHEARhd will offer 4 new, pre-set sound profiles with advanced sound processing and “more durable housing,” the company says.
iHEARhd
The next-generation iHEARhd is currently available for an introductory price of $299 per ear at the company’s online store. Consumers can opt for devices with customized settings for $399 each. The customized settings option is available for consumers who submit a recent hearing test, or take the iHEARtest™ prior to delivery of the iHEARhd directly to the consumer’s home. The iHEARtest is the “first and only FDA-cleared home hearing screener,” currently available online and in major drugstores and independent pharmacies nationwide.
For more information on iHEAR’s advanced direct-to-consumer hearing solutions, visit: http://www.ihearmedical.com
Adnan Shennib
Varun Bhardwaj, VP of Operations
The company also announced changes in management with Adnan Shennib, founder and chairman of the board for iHEAR, stepping into the Chief Executive Officer role previously held by John Luna. Shennib brings over 30 years of experience in founding and leading hearing innovations at ReSound and InSound Medical. Shennib—inventor of the Lyric hearing aid—founded InSound Medical in 1998, and holds over 100 US patents, according to an article previously published in Hearing Review. InSound Medical was later sold to Sonova in a deal totaling $169 million.
Varun Bhardwaj also joined as VP of Operations to expand the hearing solutions business in retail and online markets. Bhardwaj previously held the position of Chief Innovation Officer and brings over 12 years’ experience in management of innovations, intellectual property portfolios, and legal operations.
Source: iHEAR Medical
Images: iHEAR Medical
